CD4 and cancer: In general, the expression of receptor tyrosine kinases (RTKs) in cancer cells can activate the STAT3/5 signaling pathway, which promotes the secretion of TH2 cytokines and then promotes the survival of CD4+ Foxp3+ Tregs [95,96].